Vimta Labs Limited operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Vimta Labs Limited with three other miscellaneous service companies in Asia: Japan Tissue Engineering Company Limited of Japan (2018 sales of 2.27 billion Japanese Yen [US$20.24 million] of which 61% was Regenerative Medicine Products Business), Gene Techno Science Co Ltd of Japan (1.06 billion Japanese Yen [US$9.44 million] ), and Trans Genic Inc which is also based in Japan (3.60 billion Japanese Yen [US$32.09 million] of which 42% was TGBS business).

Sales Analysis. During the year ended March of 2018, sales at Vimta Labs Limited were 1.81 billion Indian Rupees (US$24.65 million). This is an increase of 18.1% versus 2017, when the company's sales were 1.53 billion Indian Rupees. This was the third consecutive year of growth at Vimta Labs Limited.